AI Analyst Summary
GMR Solutions Inc. presents a compelling valuation case with a forward P/E of just 7.7x — well below the healthcare sector median — implying significant re-rating potential as the company progresses toward profitability. Analyst conviction is exceptionally strong, with 7 of 8 covering analysts rating the stock a Buy and a consensus price target implying ~40% upside from current levels. The primary risk is execution: the company is currently loss-making with only modest revenue growth of 3.3% YoY and missed its sole reported EPS estimate, raising questions about the near-term path to profitability.
Fundamentals
Pe
N/A (loss-making); Forward P/E: 7.7x · 3.0/5
Trailing P/E is unavailable due to current losses, but the forward P/E of 7.7x is materially below the healthcare sector median, suggesting meaningful valuation upside if the company reaches profitability. Scored neutrally given the absence of current earnings.
Peg
N/A · 3.0/5
PEG ratio is unavailable due to lack of trailing earnings. Defaulting to neutral score of 3 per scoring guidelines. Revenue growth of 3.3% YoY is modest and does not provide a basis for upgrading the score.
Analyst Rating
Strong Buy consensus (1.5) · 5.0/5
Analyst consensus of 1.5 on the inverted scale maps to a score of 5, reflecting near-unanimous bullish sentiment. The breakdown of 7 Buy / 1 Hold / 0 Sell across 8 analysts exceeds the 5-analyst minimum threshold for full scoring weight.
Earnings Trend
N/A (YoY earnings growth unavailable); Revenue +3.3% YoY · 2.0/5
No earnings growth data is available, indicating the company is not yet profitable on a trailing basis. Revenue growth of just 3.3% YoY is below average for a healthcare facilities operator expected to be on a recovery or growth trajectory. A missed EPS beat in the only reported quarter adds further caution.
Price Target Beat
0 of 1 quarters beat · 2.0/5
Only one quarter of EPS data is available, and the company missed that quarter's estimate. Insufficient history to draw firm conclusions, but the single miss is a mild negative signal. Scored 2 given the miss and limited track record.
Management
Limited track record; 1 quarter of data with 1 miss · 2.0/5
With only one quarter of earnings history and a miss on that quarter, there is insufficient evidence of consistent execution. However, strong analyst conviction (7 of 8 rated Buy) provides some confidence in management's strategic direction. Scored conservatively given limited data.
● See the full picture
Get today's top-scored picks, ranked for you.
Compass screens thousands of stocks every morning and hands you a short list of high-conviction picks — scored, explained, and re-ranked to your risk profile.
Start free for 3 days →
No credit card. Then $9/month. Cancel anytime.
How Compass scores stocks
Compass pre-filters thousands of U.S. equities by fundamentals, then an AI analyst scores each finalist 1–5 across six measures — spanning valuation, growth, analyst sentiment, and management quality — into one composite score, refreshed every market morning. Browse all covered stocks →
Not financial advice.
Compass is an analytical tool, not a registered investment adviser or broker-dealer.
Scores and recommendations are generated by AI, may be inaccurate or out of date, and are
not investment, financial, legal, or tax advice. Investing involves risk, including loss of
principal. Do your own research and consult a licensed financial professional.
About Compass.